Cargando…
Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors
Fibroblast growth factor receptors (FGFRs), a subfamily of receptor tyrosine kinases, are aberrant in various cancer types, and considered to be promising targets for cancer therapy. We started with a weak-active compound that was identified from our internal hepatocyte growth factor receptor (also...
Autores principales: | Jiang, Alan, Liu, Qiufeng, Wang, Ruifeng, Wei, Peng, Dai, Yang, Wang, Xin, Xu, Yechun, Ma, Yuchi, Ai, Jing, Shen, Jingkang, Ding, Jian, Xiong, Bing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017193/ https://www.ncbi.nlm.nih.gov/pubmed/29562726 http://dx.doi.org/10.3390/molecules23030698 |
Ejemplares similares
-
Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors
por: Zhang, Yan, et al.
Publicado: (2017) -
Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure–activity relationship, crystal structural characterization and in vivo study
por: Wei, Peng, et al.
Publicado: (2019) -
Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers
por: Alotaibi, AbdulAziz A., et al.
Publicado: (2023) -
Virtual Screening and Structure-Based Discovery of Indole Acylguanidines as Potent β-secretase (BACE1) Inhibitors
por: Zou, Yiquan, et al.
Publicado: (2013) -
5,6-Dimethylpyrazine-2,3-dicarbonitrile
por: Bardajee, Ghasem Rezanejade, et al.
Publicado: (2012)